MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/meg.0b013e328340c451

Медицинская библиотека · European journal of gastroenterology & hepatology · 2011

Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project.

Lindenburg Catharina E A, Lambers Femke A E, Urbanus Anouk T, Schinkel Janke, Jansen Peter L M, Krol Anneke, Casteelen Gerty, van Santen Gerrit, van den Berg Charlotte H S B, Coutinho Roel A, Prins Maria, Weegink Christine J

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Although hepatitis C virus (HCV) treatment has shown to be effective, uptake of treatment among active drug users is still low. The Drug Users Treatment for Chronic Hepatitis-C project aims to offer active drug users in Amsterdam HCV testing and treatment using a multidisciplinary approach.

METHODS

The study population comprises drug users participating in the Amsterdam Cohort Studies and drug users referred to the Drug Users Treatment for Chronic Hepatitis-C unit. Drug users were offered HCV testing and, if chronically infected, medical and psychiatric screening and HCV treatment. Various specialists collaborated to provide optimal care. We assessed test-uptake and treatment-uptake and outcomes.

RESULTS

Four hundred and ninety-seven Amsterdam Cohort Studies drug users were offered HCV testing: 449 out of 497 (90%) accepted. HCV antibodies were found in 267 out of 449 (60%): 183 out of 267 (69%) were HCV-viremic and 49 out of 183 (27%) were HIV-co-infected. Of the 134 HCV-monoinfected patients, 102 (76%) initiated additional medical screening and 44 started treatment by 1 July 2009. Sixty-two drug users referred from methadone clinics were also HCV-monoinfected, of whom 14 started treatment by 1 July 2009. In total 58 persons were treated: 16 (27%) with genotype 1 or 4, 42 (72%) with genotype 2 or 3. Eighty-four percent used methadone, 97% used drugs (heroin, cocaine or amphetamine) at least once in the 6 months before treatment, 19% were active injectors. Sixty-two percent used alcohol, 41% had psychiatric disease other than substance abuse. Of the 57 individuals with sufficient follow-up, 37 (65%) achieved sustained virological response.

CONCLUSION

In a multidisciplinary setting, HIV-negative drug users with chronic HCV infection can be treated successfully despite active drug or alcohol use and psychiatric diseases. Therefore, access to HCV therapy using an integrated approach should be increased for this population.

Для цитирования: Lindenburg Catharina E A, Lambers Femke A E, Urbanus Anouk T, Schinkel Janke, Jansen Peter L M, Krol Anneke, Casteelen Gerty, van Santen Gerrit, van den Berg Charlotte H S B, Coutinho Roel A, Prins Maria, Weegink Christine J. Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project.. European journal of gastroenterology & hepatology. 2011. DOI: 10.1097/meg.0b013e328340c451.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.